Cargando…
A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
Numerous clinical trials of drug candidates for Alzheimer’s disease (AD) have failed, and computational drug repositioning approaches using omics data have been proposed as effective alternative approaches to the discovery of drug candidates. However, little multi-omics data is available for AD, due...
Autores principales: | Lee, Soo Youn, Song, Min-Young, Kim, Dain, Park, Chaewon, Park, Da Kyeong, Kim, Dong Geun, Yoo, Jong Shin, Kim, Young Hye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000455/ https://www.ncbi.nlm.nih.gov/pubmed/32063857 http://dx.doi.org/10.3389/fphar.2019.01653 |
Ejemplares similares
-
Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning
por: Kim, Yoonbee, et al.
Publicado: (2022) -
Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
por: Rabben, Hanne-Line, et al.
Publicado: (2021) -
Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017) -
Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022) -
Proteotranscriptomics – A facilitator in omics research
por: Levin, Michal, et al.
Publicado: (2022)